Category: Health
Blarcamesine, an investigational agent developed by Anavex Life Sciences
Blarcamesine, an investigational agent developed by Anavex Life Sciences, has shown promising results in a phase 2 extension study for Parkinson’s disease dementia (PDD). The study, ANAVEX2-73-PDD-EP-001, demonstrated that blarcamesine met its primary and secondary objectives in a cohort of individuals with PDD. Despite a delay in the trial due to the COVID-19 pandemic, patients…
Read More